Related Experiment Video
Updated: Jun 19, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing
Stanzi M le Roux1, Mark F Cotton, Jonathan E Golub
1School of Child and Adolescent Health, University of Cape Town, South Africa. stanzi.leroux@gmail.com
Insights
Adherence to isoniazid prophylaxis in HIV-infected children was excellent with both daily and three times weekly dosing. Intermittent dosing is a viable alternative to daily regimens, ensuring optimal adherence and efficacy for tuberculosis prevention.
Area of Science:
- Public Health
- Infectious Diseases
- Pediatrics
Background:
- Tuberculosis (TB) significantly impacts HIV-infected children in sub-Saharan Africa.
- Isoniazid prophylaxis reduces TB incidence but requires optimized adherence.
- This study investigated adherence predictors for isoniazid in HIV-infected children.
Purpose of the Study:
- To compare adherence to daily versus three times weekly isoniazid prophylaxis in HIV-infected children.
- To identify predictors of adherence to isoniazid prophylaxis in this population.
Main Methods:
- A randomized trial at two tertiary pediatric centers in Cape Town, South Africa.
- 324 HIV-infected children aged >or= 8 weeks were followed for 5 years.
- Adherence assessed via pill counts; >or= 90% considered optimal; logistic regression with GEE used.
Main Results:
- Overall adherence was excellent (94.7%), with no significant difference between daily (93.8%) and thrice-weekly (95.5%) schedules.
- 78.6% of children achieved optimal adherence (>or= 90%).
- Overcrowded homes predicted lower adherence; older children (>4 years) showed better adherence.
Conclusions:
- Excellent isoniazid adherence is achievable with both daily and intermittent (3x/week) dosing schedules.
- Intermittent isoniazid prophylaxis is a suitable alternative to daily dosing for TB prevention in HIV-infected children.
- Adherence is influenced by socioeconomic factors and age.
Background:
Tuberculosis contributes significantly to morbidity and mortality among HIV-infected children in sub-Saharan Africa. Isoniazid prophylaxis can reduce tuberculosis incidence in this population. However, for the treatment to be effective, adherence to the medication must be optimized. We investigated adherence to isoniazid prophylaxis administered daily, compared to three times a week, and predictors of adherence amongst HIV-infected children.
Methods:
We investigated adherence to study medication in a two centre, randomized trial comparing daily to three times a week dosing of isoniazid. The study was conducted at two tertiary paediatric care centres in Cape Town, South Africa. Over a 5 year period, we followed 324 HIV-infected children aged >or= 8 weeks. Adherence information based on pill counts was available for 276 children. Percentage adherence was calculated by counting the number of pills returned. Adherence >or= 90% was considered to be optimal. Analysis was done using summary and repeated measures, comparing adherence to the two dosing schedules. Mean percentage adherence (per child during follow-up time) was used to compare the mean of each group as well as the proportion of children achieving an adherence of >or= 90% in each group. For repeated measures, percentage adherence (per child per visit) was dichotomized at 90%. A logistic regression model with generalized estimating equations, to account for within-individual correlation, was used to evaluate the impact of the dosing schedule. Adjustments were made for potential confounders and we assessed potential baseline and time-varying adherence determinants.
Results:
The overall adherence to isoniazid was excellent, with a mean adherence of 94.7% (95% confidence interval [CI] 93.5-95.9); similar mean adherence was achieved by the group taking daily medication (93.8%; 95% CI 92.1-95.6) and by the three times a week group (95.5%; 95% CI 93.8-97.2). Two-hundred and seventeen (78.6%) children achieved a mean adherence of >or= 90%. Adherence was similar for daily and three times a week dosing schedules in univariate (odds ratio [OR] 0.88; 95% CI 0.66-1.17; P = 0.38) and multivariate (adjusted OR 0.85; 95% CI 0.64-1.11; P = 0.23) models. Children from overcrowded homes were less adherent (adjusted OR 0.71; 95% CI 0.54-0.95; P = 0.02). Age at study visit was predictive of adherence, with better adherence achieved in children older than 4 years (adjusted OR 1.96; 95% CI 1.16-3.32; P = 0.01).
Conclusion:
Adherence to isoniazid was excellent regardless of the dosing schedule used. Intermittent dosing of isoniazid prophylaxis can be considered as an alternative to daily dosing, without compromising adherence or efficacy.
Trial Registration:
Clinical Trials NCT00330304.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Dosage Regimens: Designs and Approaches